• Journal of the Korea Institute of Information and Communication Engineering
• /
• v.19 no.8
• /
• pp.1845-1852
• /
• 2015

From bar code systems and radio frequency identification (RFID) to beacons utilizing low power bluetooth technology, the fusion of information technology and health and medical treatment is spreading through advances such as automated treatment and examination stages and the use of treatment information connected to smart devices. In this paper, designed and implemented a mobile health care system for the safe management of blood transfusions to prevent accidental problems that can occur during patient blood transfusions. It makes safe and effective blood transfusion possible by using smart devices to read information saved on patient bracelets, blood-collecting containers, blood transfusion bags, and medical personnel identification cards so that they match patient information. By applying the blood transfusion management mobile health care system presented and implemented in this paper to blood transfusion processes in hospitals, it was verified that it allows for safe and effective blood transfusion, preventing accidents which may occur in blood transfusion processes.

• RED RIBBON
• /
• s.67
• /
• pp.24-25
• /
• 2005

최근 항체미형성기의 오염혈액을 2003년 8월 수혈받은 2명이 에이즈의 원인병원체인 HIV(인면역결핍바이러스)에 감염된 사실이 언론에 발표되었다. 다행스럽게도 수혈감염자로부터 2차 감염은 이루어지지 않았으나 얼마 전 HIV 항체미형성기의 혈장을 원료로 한 알부민제제 시판 논란과 더불어 일반 국민들은 국가혈액공급의 안전에 큰 불안을 갖게 되었다.

• Korean Journal of Clinical Laboratory Science
• /
• v.55 no.1
• /
• pp.65-70
• /
• 2023

The effect of improvement by keeping the former as the priority was examined through an evaluation of the role of the blood transfusion management (BTM) division. This division manages the status of blood for transfusion, evaluates the adequacy of blood transfusion (EABT), monitors and responds to the occurrence of transfusion-related side effects, and performs other tasks necessary for BTM. Although the establishment and operation of the BTM division can lead to the efficient evaluation of transfusion adequacy, there are disadvantages in that it takes time for EABT and it is difficult for the staff in charge of the BTM division to evaluate the adequacy of all the blood. In the future, it is essential to introduce a BTM division and committee specific to Korean patients to implement safe and appropriate BTM in medical institutions, and to assist medical institutions in training their personnel.

• RED RIBBON
• /
• s.58
• /
• pp.22-25
• /
• 2004

국내에서 수혈되는 혈액에 대해서도 선진국에서 실시하고 있는 핵산증폭검사가 올해 하반기부터 적용될 예정이다. 핵산증폭검사의 실시로 혈액제제로 안전성은 그 어느 때보다도 높아질 예정이다.

• RED RIBBON
• /
• s.55
• /
• pp.16-17
• /
• 2003

올해는 어느 해보다 수혈관련 사건이 많이 일어났다. 그 여파로 오염된 혈액이 혈액제제로 사용됐음을 문제삼는 기사가 유난히 많았던 한 해였다. 언론에서 보도하는 것처럼 혈액제제는 정말 신뢰할 수 없는 것인가?

• Journal of Korean Academy of Fundamentals of Nursing
• /
• v.22 no.2
• /
• pp.180-189
• /
• 2015

Purpose: The purpose of this study was to identify the types of errors that occurred and were recovered in a simulated transfusion scenario by nursing students. Methods: Twenty-eight teams of a total of 89 nursing students participated in a transfusion simulation using a high fidelity simulator. Data were collected by observing rule based errors and built in errors recovered according to the framework of Eindhoven model. Reflective journaling was used to identify perceived safety-threatening errors and commitment to improvement. Data were analyzed using descriptive statistics. Results: All teams committed the rule based errors in the scenario. The most common errors occurred in the coordination category related to communication with physician. Most of students perceived the transfusion reaction as a safety-threatening error. Conclusion: The findings indicate that students lack patient safety competence. The simulation training to decrease errors and improve safe practice provides nursing students with an effective strategy to develop patient safety competence.

• Korean Journal of Clinical Laboratory Science
• /
• v.48 no.1
• /
• pp.36-40
• /
• 2016

Red blood cell (RBC) alloimmunization results from genetic disparity of RBC antigens between donor and recipients. The discrepancy of RBC antibody screening test occurs when the results of red cell tests do not agree with those of the serum test. In order to select the proper blood units for transfusion, clarification of the cause of discrepancies is essential. The RBC antibody screening test is an easy, quick, and reliable method for detection of clinically significant antibodies. Antibody screening and identification is recommended prior to transfusion to determine whether there is blood group incompatibility. We reported that phenotyping for E, D, M, E+c, and C+e antibody screening test should be extended. Therefore, these results indicate that anti-D and anti-E alloantibodies were major risk factors for haemolytic disease of the newborn or delayed haemolytic transfusion reactions in this study population. We suggested that its antibody screening be adapted to blood safety interventions. Targeted screening of selected recipients at risk offers less value than universal antibody screening, and more research is needed to determine the real incidence of this national condition.

• The Korean Journal of Blood Transfusion
• /
• v.29 no.3
• /
• pp.262-272
• /
• 2018

Background: Massive hemorrhage due to trauma is one of the major causes of death in trauma patients, and the quick supply of appropriate blood products is critical in order to reduce the mortality rate. We introduced a massive transfusion protocol (MTP) for safe and rapid transfusion of trauma patients. Using records collected since its adoption, we compared the characteristics of MTP applied group (MTP group) and MTP not applied group (non-MTP group) to determine whether there is an indicator for predicting patients to be treated with MTP. Methods: We retrospectively reviewed the electronic medical records and laboratory findings of patients who received massive transfusions in the trauma emergency room of a single tertiary hospital from February to August 2018. We analyzed various laboratory test results, the amount and ratio of the transfused blood products, and the time required for blood products to be released for the MTP group and the non-MTP group. Results: Of the 54 trauma patients who received massive transfusions, 31 were in the MTP group and 22 in the non-MTP group. There was no significant difference in initial vital signs (except blood pressure) and laboratory test results. Also there was no difference in the amount and ratio of blood products, but the time required for blood product release was shorter in the MTP group. Conclusion: There was no significant difference in clinical findings such as initial vital signs and laboratory test results between the MTP and non-MTP groups, but required blood products were prepared and released more quickly for the MTP group.

• RED RIBBON
• /
• s.68
• /
• pp.14-15
• /
• 2006

최근 수혈로 인해 에이즈에 감염되는 사례가 발생함에 따라 정부에서는 에이즈 등 법정전염병의 병력자 명부를 대한적십자사에 제공하여 혈액의 안전성을 확보하고자 하였다. 하지만 정부의 이러한 방침에 대해 감염인 및 인권단체들은 정부의 법정전염병 병력자 정보 제공은 병력자들에 대한 인권침해라며 크게 반발하고 있다. 과연 그들이 우려하는 바는 무엇인가?

• The Korean Journal of Blood Transfusion
• /
• v.29 no.3
• /
• pp.301-309
• /
• 2018

Background: If donors who were deferred due to the reactivity or grey zone in HBV surface antigen (HBsAg) assay want to donate blood again, they need to pass reentry tests. On the other hand, approximately half of the donors who are subject to the reentry tests cannot be reentered. This study examined the association between the sample to cutoff (S/Co) value of the HBsAg assay and the final results of the reentry test. Methods: This study analyzed the S/Co values of the HBsAg assay and the final results of the reentry tests for the 3,947 donors from January 2008 to December 2017 using the database of Blood Information Management System of the Korean Red Cross. Results: 1,767 donors (44.8%) were not reentered among 3,947 deferred donors. Among 1,585 donors showing ${\geq}10$ of the S/Co value in the HBsAg screening test, 1,542 donors (97.3%) were not reentered. The additional reentry tests were performed on 120 donors who were not reentered in the first reentry test; 98 donors (81.7%) were still not reentered. Overall, 4.6% of the donors showing a grey zone in the HBsAg assay were not reentered. Conclusion: The reentry test needs to be restricted for the deferred donors showing a more than 10 S/Co value. The application of the grey zone of current HBsAg assay will need to be continued to enhance the HBV-related blood safety.